About the Product

Description


Vancoterm 500 Injection contains Vancomycin, a powerful antibiotic belonging to the glycopeptide class. It is formulated to combat severe bacterial infections, particularly those caused by Gram-positive pathogens. Vancomycin is renowned for its efficacy in treating methicillin-resistant Staphylococcus aureus (MRSA), severe skin and soft tissue infections, septicemia, endocarditis, bone and joint infections, and infections associated with implanted medical devices.

The mechanism of action involves inhibition of bacterial cell wall synthesis, which leads to bacterial cell death. This makes Vancoterm 500 an essential choice for combating multidrug-resistant bacteria. It is typically administered intravenously, ensuring rapid and direct delivery to the bloodstream for systemic infections.

This injection is frequently used in hospitalized patients and critical care settings, especially when other antibiotics are ineffective or unsuitable. Vancomycin is often reserved for cases requiring precise treatment of resistant infections, ensuring the most effective results in complex medical scenarios.

Potential side effects include skin rash, itching, pain at the injection site, flushing, and, in rare cases, kidney dysfunction or hearing loss.

Effective for treating severe Gram-positive bacterial infections, including MRSA, septicemia, and severe skin, bone, and joint infections.

Vancoterm 500 Injection should only be used under medical supervision. Dosage adjustments are required for patients with renal impairment. Report any adverse reactions promptly to your healthcare provider.

Store below 25°C, away from light and moisture. Ensure it is kept out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Vancomycin 500mg Injection in the PCD pharma franchise market?

Vancomycin 500mg Injection has strong demand in the critical care, infectious disease, hospital care, and intensive care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced injectable antibiotic portfolios.

Why should medical distributors include Vancomycin 500mg Injection in their product range?

Medical distributors and agencies can benefit from consistent demand for serious Gram-positive bacterial infection management under specialist medical supervision. Vancomycin 500mg is a glycopeptide antibiotic used to treat severe infections caused by susceptible Gram-positive bacteria Commonly prescribed for MRSA infections, septicemia, endocarditis, pneumonia, bone and joint infections, skin and soft tissue infections, and other complicated bacterial infections Frequently utilized in ICUs, tertiary care hospitals, emergency departments, and infectious disease units Plays an important role in the treatment of infections caused by resistant Gram-positive organisms when clinically indicated Widely prescribed by infectious disease specialists, intensivists, physicians, and surgeons This strengthens a comprehensive critical care and anti-infective portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Vancomycin 500mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong hospital demand, institutional procurement opportunities, specialty antibiotic usage, reliable supply chain support, and attractive margins in the critical care segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.